TY  - JOUR

T1  - Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial

JO  - Clinical Cancer Research

UR  - https://doi.org/10.1158/1078-0432.ccr-26-1365

PY  - 2026/09/09

AU  - Middleton G

AU  - Buchanan R

AU  - Savage J

AU  - De La Mata Chicharro J

AU  - Mehmi M

AU  - Wilkins RJ

AU  - Kelly RDW

AU  - Wilson C

AU  - Kanhere A

AU  - Robbins HL

AU  - Ames L et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-26-1365

PB  - American Association for Cancer Research (AACR)

Y2  - 2026/09/20

ER  -